MoonLake Immunotherapeutics (MLTX) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 102 transactions totaling $208.0M, demonstrating a bullish sentiment with $44.5M in net insider flow. The most recent transaction on Dec 19, 2025 involved a transaction of 196,316 shares valued at $0.
No significant insider buying has been recorded for MLTX in the recent period.
No significant insider selling has been recorded for MLTX in the recent period.
Based on recent SEC filings, insider sentiment for MLTX is bullish with an Insider Alignment Score of 61/100 and a net flow of $44.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at MoonLake Immunotherapeutics (MLTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading MLTX stock, having executed 102 transactions in the past 90 days. The most active insider is Bihua Chen (Executive), who has made 34 transactions totaling $105.8M.
Get notified when executives and directors at MLTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Silva Jorge Santos Da | Executive | Conversion | 196,316 | $N/A | $0 | |
| Dec 19, 2025 | Silva Jorge Santos Da | Executive | Disposition | 196,316 | $N/A | $0 | |
| Dec 19, 2025 | Reich Kristian | Executive | Conversion | 35,389 | $N/A | $0 | |
| Dec 19, 2025 | Reich Kristian | Executive | Disposition | 35,389 | $N/A | $0 | |
| Dec 19, 2025 | Bodenstedt Matthias | Executive | Disposition | 294,473 | $N/A | $0 | |
| Dec 19, 2025 | Bodenstedt Matthias | Executive | Conversion | 294,473 | $N/A | $0 | |
| Dec 9, 2025 | Reich Kristian | Executive | Sale | 72,908 | $14.43 | $1.1M | Large |
| Dec 9, 2025 | Silva Jorge Santos Da | Executive | Sale | 70,000 | $14.49 | $1.0M | Large |
| Dec 8, 2025 | Reich Kristian | Executive | Sale | 130,000 | $15.08 | $2.0M | Large |
| Dec 8, 2025 | Silva Jorge Santos Da | Executive | Sale | 130,000 | $15.08 | $2.0M | Large |
| Oct 8, 2025 | Bodenstedt Matthias | Executive | Purchase | 10,870 | $9.09 | $98.8K | |
| Sep 30, 2025 | Healthcare Master Fund, Lp Cormorant Global | Executive | Sale | 5,827 | $6.96 | $40.6K | |
| Sep 29, 2025 | Healthcare Master Fund, Lp Cormorant Global | Executive | Sale | 2,800,000 | $6.61 | $18.5M | Large |
| Sep 29, 2025 | Healthcare Master Fund, Lp Cormorant Global | Executive | Sale | 3,390,943 | $7.58 | $25.7M | Large |
| Sep 29, 2025 | Healthcare Master Fund, Lp Cormorant Global | Executive | Sale | 70,748 | $9.38 | $663.6K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 38 | $126.2M | 60.7% |
Sale(S) | 33 | $81.7M | 39.3% |
Conversion(C) | 16 | $0 | 0.0% |
Disposition(D) | 14 | $0 | 0.0% |
Exercise(M) | 1 | $0 | 0.0% |
Insiders at MoonLake Immunotherapeutics are accumulating shares at an accelerated pace. With 10 insiders making 102 transactions totaling $126.2M in purchases versus $81.7M in sales, the net buying activity of $44.5M signals strong executive confidence. Bihua Chen (Executive) leads the buying activity with $105.8M in transactions across all time.